FDA Guidance Smoothes Advair Generic Approval Process
The U.S Food and Drug Administration on Monday issued a draft guidance on how drugmakers should test any planned generic version of GlaxoSmithKline PLC's blockbuster asthma drug Advair, potentially smoothing the...To view the full article, register now.
Already a subscriber? Click here to view full article